Position: PhD position: Development of novel concepts for Nuclear Medicine (prostate cancer), part-time (65%)
Department: DKTK Freiburg, Department of Nuclear Medicine - Division of Radiopharmaceutical Development
Code number: 2020-0215
The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.
Together with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK).
For the partner site of DKTK Freiburg the German Cancer Research Center is looking for a scientist with experience in the field of radiopharmacy.
The PhD position is located in Freiburg and immediately available at the University Medical Center Freiburg, Department of Nuclear Medicine, focusing on the identification of novel radiopharmaceuticals (www.uniklinik-freiburg.de/nuklearmedizin/radiopharmakaentwicklung).
The clinically oriented research platform includes the identification and evaluation of novel radiopharmaceuticals for positron emission tomography (PET) and radionuclide therapy. The multidisciplinary and translational focus is supported by the direct association with the Comprehensive Cancer Center Freiburg and the German Cancer Consortium (DKTK).
The candidate will work in a highly interdisciplinary field encompassing pharmaceutical sciences, chemistry, biotechnology, medicine, and biology. Innovative biotechnological and chemical methods will be used to identify novel compounds.
The specific topic of the current doctoral thesis deals with the identification of novel drug candidates for therapy of metastatic prostate cancer. Within the scope of the project, radiopharmaceuticals against new target structures will be identified by biological screening systems such as mRNA-based display or phage display. The project is highly interdisciplinary emphasized by a broad spectrum of methods in biotechnology, biochemistry and molecular biology. The approaches applied will result in novel diagnostic procedures and potentially new therapeutic options for the treatment of advanced prostate cancer.
We are looking for candidates with interest in a challenging and application-oriented research topic as well as the ability to work independently in a team. The candidate should have an above-average master's degree in molecular/cancer biology, biochemistry, or related biomedical fields. Exceptional written and oral communication skills, self-motivation, ability to work in a team-oriented setting in an interdisciplinary environment are required. Experience in molecular biology and biochemistry is highly desired. The candidate is expected to present the research at national and international conferences.
Please hand in:
- Letter of intent
- Curriculum Vitae
- Certified copies of your university degrees with grades (BA and MA certificate / Diploma certificate)
- Suggestion of two referees with contact details
- Interesting, versatile workplace
- International, attractive working environment
- Campus with modern state-of-the-art infrastructure
- Access to international research networks
- Doctoral student payment including social benefits
- Flexible working hours
- Comprehensive training and mentoring program through the Helmholtz International Graduate School
Earliest Possible Start Date: as soon as possible
Duration: The position is limited to 3 years.
Application Deadline: 01.10.2020
Prof. Dr. Matthias Eder
Phone +49 761270 74220
Please note that we do not accept applications submitted via email.